Double Helix Biotechnology Dev. has been acquired by Interpublic Group of Companies
Double Helix Bio-Technology Development Ltd. (Double Helix), a leading, global provider of market research and market access services to the pharmaceutical and medical device industries, has been sold to McCann Health, owned by The Interpublic Group of Companies Inc. Financial details of this transaction have not been disclosed.
Founded by Dr Wayne Phillips and based in London, Double Helix not only specializes in the established markets of the US and Europe, but also focuses on emerging markets, providing clients with a truly global perspective. In the past year, Double Helix has performed projects across more than 40 countries for over 30 major pharmaceutical multinational clients. Dr Phillips will continue as CEO of Double Helix, reporting to John Cahill, CEO of McCann Health.
McCann Health is a part of McCann Worldgroup, the largest marketing communications agency network in the world, and is a leading healthcare agency network owned by The Interpublic Group of Companies Inc.
Oaklins Cavendish, based in the UK, acted as financial advisor to the seller.
Talk to the deal team
Lord Leigh of Hurley
Oaklins Cavendish
Related deals
iwell raises US$31 million to deploy its leading European smart battery storage solutions into new markets
iwell, a developer of smart energy management (EMS) and battery storage systems (BESS), has successfully closed a US$31 million (€27 million) funding round. The round was led by Meridiam, with Invest-NL and Rabobank participating, alongside existing investors.
Learn moreBezeq Online has been acquired by One Software Technologies
Bezeq Online has been acquired by ONE Software Technologies Ltd., enabling ONE Technologies to offer innovative solutions through full integration of advanced technology, real-time data analysis and proven service capabilities nationwide. ONE Technologies’ goal is to develop the next generation of service solutions, including AI-based tools, automation, multi-channel digital services and advanced CRM systems, all designed to deliver a continuous, accurate and effective customer experience.
Learn morePharma-Skan & Skan-Medic have been acquired by Brygge Partners
Pharma-Skan, an independent contract manufacturing organization (CMO), and Skan-Medic, a manufacturer of over-the-counter (OTC) products, both operating as a joint entity, have been acquired by Brygge Partners.
Learn more